An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers
Open Access
- 1 August 2007
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 110 (3), 886-893
- https://doi.org/10.1182/blood-2007-01-070953
Abstract
Severe deficiency of ADAMTS13, a von Willebrand factor (VWF)–cleaving metalloprotease, causes thrombotic thrombocytopenic purpura. When analyzed with VWF multimers, but not with an abbreviated VWF peptide (VWF73) as the substrate, the plasma ADAMTS13 activity levels of mouse strains segregated into a high and a low group that differed by approximately 10 fold. Low ADAMTS13 activity was detected in mice containing 2 alleles of intracisternal A-type particle (IAP) retrotransposon sequence in the ADAMTS13 gene. Molecular cloning of mouse ADAMTS13 identified 2 truncated variants (IAP-a and IAP-b) in the low-activity mice. Both of the IAP variants lacked the 2 carboxyl terminus thrombospondin type 1 repeat (TSR) and CUB domains of full-length ADAMTS13. The IAP-b variant also had splicing abnormalities affecting the spacer domain sequence and had miniscule enzymatic activity. Compared with full-length ADAMTS13, the IAP-a variant was approximately one ninth as active in cleaving VWF multimers but was only slightly less active in cleaving VWF73 peptide. Recombinant human ADAMTS13 was also less effective in cleaving VWF multimers than VWF73 when the C-terminal TSR sequence was deleted. In summary, the carboxyl terminus TSR sequence is important for cleaving VWF multimers. Assay results should be interpreted with caution when peptide substrates are used for analysis of variant ADAMTS13 proteins.Keywords
This publication has 33 references indexed in Scilit:
- Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse modelJournal of Thrombosis and Haemostasis, 2007
- Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloproteaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf geneBlood, 2006
- Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid raftsBlood, 2006
- Current Concepts in Thrombotic Thrombocytopenic PurpuraAnnual Review of Medicine, 2006
- Involvement of human intracisternal A‐type retroviral particles in autoimmunityMicroscopy Research and Technique, 2005
- Platelet-derived VWF-cleaving metalloprotease ADAMTS-13Journal of Thrombosis and Haemostasis, 2005
- Binding of ADAMTS13 to von Willebrand FactorJournal of Biological Chemistry, 2005
- An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutationsThrombosis and Haemostasis, 2004
- Formation of an active form of the interleukin‐2/15 receptor β‐chain by insertion of the intracisternal A particle in a radiation‐induced mouse thymic lymphoma and its role in tumorigenesisMolecular Carcinogenesis, 2003